Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-016207
Filing Date
2020-06-11
Accepted
2020-06-11 20:33:45
Documents
2
Period of Report
2020-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3534
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4775
  Complete submission text file 0000899243-20-016207.txt   9743
Mailing Address C/O AEGLEA BIOTHERAPEUTICS, INC. 901 S. MOPAC EXPWY, STE. 250 AUSTIN TX 78746
Business Address
Quinn Anthony G. (Reporting) CIK: 0001532219 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39319 | Film No.: 20958586

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Issuer) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations